Ajuts a la recerca

Epilepsy Foundation: New Therapy - Commercialization Grants Program

Organisme

The mission of the New Therapy - Commercialization Grants Program is to drive the development of new therapies for epilepsy, accelerating the advancement of research from the laboratory to the patient. Funding is provided to academic and commercial groups worldwide

Objecte

The Program seeks to advance the development of new therapies including but not limited to medicines, biologics or devices. All proposals must demonstrate a clear path from the lab to the patient and are evaluated with consideration for their potential value to patients, likelihood of successful development including regulatory approval and the timeframe of development. The Program also encourages 1:1 matching grants to academic and commercial entities to support the commercialization of novel approaches to the treatment of epilepsy. Preference will be given to proposals that already have a commercial partner engaged to assist with development, and to proposals that have committed or matched funding from a sponsoring institution, commercial partner or other third party source.

Termini oficial

Letter of Intent due: March 7, 2014, 11:59 PM ET
If LOI is accepted, APPLICATION is due: April 21, 2014, 11:59 PM ET

Termini IISPV

Declaration of interest: IISPV's deadline: February 19, 2014 (europa@iispv.cat). IISPV LOI- February 28, 2014 - If LOI is accepted, Full proposal: IISPV's deadline: April 15, 2014

Pujar